Dr Michael McBride receives his first jab as the vaccination programme in Northern Ireland opened to those aged 50 and above. The latest phase of the rollout was announced after the Irish Republic joined a number of other European countries in temporarily suspending use of the Oxford/AstraZeneca vaccine after reports from Norway of a small number of vaccinated people who had developed serious blood clots.